LONDON, UK / ACCESSWIRE / September 29, 2017 / Pro-Trader Daily takes a look at the latest corporate events and news making the headlines for Mitcham Industries, Inc. (NASDAQ: MIND) (“Mitcham”), following which we have published a free report that can be viewed by signing up at http://protraderdaily.com/optin/?symbol=MIND. The Company announced on September 27, 2017, that it has entered into a rental partnership agreement with INOVA Geophysical, Inc. (“INOVA”), pursuant to which the former will make worldwide use of INOVA’s onshore seismic acquisition products. For immediate access to our complimentary reports, including today’s coverage, register for free now at:

http://protraderdaily.com/register/

At Pro-TD, we make it our mission to bring you news that matter about the stock you follow. Today, our research desk covers a blog story on MIND. Go directly to your stock of interest and access today’s free coverage at:

http://protraderdaily.com/optin/?symbol=MIND

The rental agreement also includes the new Quantum nodal system, developed in collaboration with Innoseis, G3i HD cable system channels, Hawk multi-channel nodal stations, analog and digital sensors, and Vib Pro HD controllers and vibrators.

Quantum Nodal System

Quantum nodes integrated with iX1 command and control system provides a complete, full-featured nodal acquisition system aimed at meeting the demand for high density, cost-effective onshore seismic survey.
It also provides a solution for traditional surveys as well as the flexibility to meet tomorrow’s exploration challenges.
Quantum is the lightest, longest battery life node currently available, offering reduced transportation and deployment costs and minimizing field battery management.
iX1 is a single Seismic Operational Management System for front-end operations and QC.

G3i HD Cable System Channels

INOVA’s G3i HD and Hawk systems are field proven cable and cable-less solutions that are also integrated with iX1.
Integration with iX1 allows hybrid deployments of mixed equipment types managed from a single iX1 front end, providing seamless operation across a variety of surface conditions.
G3i HD and Hawk systems are used worldwide today.

Vib Pro HD Controllers and Vibrators

INOVA’s vibroseis vehicles, combined with Vib Pro HD, are industry leading source products synonymous with reliability and exceptional broadband performance.
Vibrators are offered in a range of weight class from small, highly-maneuverable vehicles to large, heavy-weight vehicles.
Vibrators provide source solutions for a variety of environments and imaging objectives.

Mitcham Reports Fiscal 2018 Q2 Results

Mitcham announced its financial results on September 07, 2017, for the second quarter of the fiscal year 2018 ended July 31, 2017. During Q2 FY18, the Company’s total revenue increased 25.1% to $10.84 million from $8.66 million in Q2 FY17. For the reported quarter, the Company’s gross profit was $618,000 compared to a gross loss of $2.24 million in Q2 FY17. During Q2 FY18, Mitcham’s operating loss was $4.97 million compared to an operating loss of $8.32 million in Q2 FY17. During Q2 FY18, the Company’s net loss was $5.57 million compared to a net loss of $9.64 million in Q2 FY17.

About Mitcham Industries, Inc.

Founded in 1987, Mitcham is the largest independent lessor of advanced seismic equipment in the world. Through its Seamap business unit, the Company also designs, manufactures, sells, and service specialized equipment for the marine segment of the seismic industry. Mitcham is headquartered in Huntsville, Texas.

About INOVA Geophysical Inc.

Established in 2010, INOVA develops land seismic equipment that meets the demands of acquisition in any operating environment. The Company was formed when BGP and ION Geophysical Corp. each contributed land seismic equipment assets to a new and independent joint venture Company.

Last Close Stock Review

On Thursday, September 28, 2017, the stock closed the trading session at $3.44, slightly up 0.29% from its previous closing price of $3.43. A total volume of 4.66 thousand shares have exchanged hands. Mitcham Industries’ stock price rallied 1.47% in the last one month and 14.67% in the previous twelve months. The stock currently has a market cap of $41.73 million.

Pro-Trader Daily:

Pro-Trader Daily (Pro-TD) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and Canadian stocks. PRO-TD has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles, and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

PRO-TD has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the “Author”) and is fact checked and reviewed by a third party research service company (the “Reviewer”) represented by a credentialed financial analyst [for further information on analyst credentials, please email contact@protraderdaily.com. Rohit Tuli, a CFA® charter-holder (the “Sponsor”), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by PRO-TD. PRO-TD is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

PRO-TD, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. PRO-TD, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, PRO-TD, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither PRO-TD nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://protraderdaily.com/disclaimer/.

CONTACT

For any questions, inquiries, or comments reach out to us directly. If you’re a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:

Email: contact@protraderdaily.com

Phone number: (917) 341.4653

Office Address: Mainzer Landstrasse 50 Frankfurt am Main, Germany 60325

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: Pro-Trader Daily

ReleaseID: 476646

LONDON, UK / ACCESSWIRE / September 29, 2017 / Pro-Trader Daily takes a closer look at Physicians Realty Trust (NYSE: DOC) as the Company’s stock will begin trading ex-dividend on October 02, 2017. To capture the dividend payout, investors must purchase the stock a day prior (excluding weekend) to the ex-dividend date that is by latest at the end of the trading session on September 29, 2017. Are you looking for research on dividend stocks, if so register with us now for your free membership at:

http://protraderdaily.com/register/

Today, PRO-TD covers ex-dividend news on DOC. Get our free coverage by signing up at:

http://protraderdaily.com/optin/?symbol=DOC

Dividend Declared

On September 21, 2017, Physicians Realty announced that the Company’s Board of Trustees has authorized a quarterly cash dividend of $0.230 per common share and unit for the quarter ending September 30, 2017. The dividend will be payable on October 18, 2017, to common shareholders and unitholders of record on October 03, 2017.

Physicians Realty’s indicated dividend represents a yield of 5.15%, which is substantially above the average dividend yield of 3.15% for the financial sector.

Dividend Insights

Physicians Realty has a dividend payout ratio of 86.0%, which means that the Company distributes approximately $0.86 for every $1.00 earned. The dividend payout ratio reflects how much amount a company is returning to shareholders versus how much money it is keeping on hand to reinvest in growth, to pay off debt, and/or to add to its cash reserves.

According to analysts’ estimates, Physicians Realty Trust is forecasted to report earnings of $0.34 for the next year compared to the Company’s annualized dividend of $0.92. Physicians Realty Trust is a Real Estate Investment Trust (REIT) which is structured by law to distribute at least 90% of earnings. Moreover, since REITs generate income from owning portfolios of investment real estate, they are likely to have higher depreciation charges.

Since depreciation is a non-cash charge, it does not directly impact the ability of dividend the Companies can distribute. For this reason, Fund from Operations (FFO) is calculated by adding depreciation and amortization to earnings and subtracting any gains on sales which provides a better picture of any company’s profitability and capacity to pay and to sustain dividends. For instance, Physicians Realty Trust’s net income attributable to common shareholders for Q2 2017 was $0.06 per diluted share. The Company’s FFO for Q2 2017 consisted of net income less $0.2 million of net income attributable to non-controlling interests for partially owned properties, plus $28.1 million of depreciation and amortization, less $0.1 million of depreciation and amortization expense for partially owned properties, less $0.2 million of preferred distributions, less $5.3 million of gain on sale of investment property, resulting in $0.20 per diluted share. Physicians Realty Trust’s normalized FFO, which adjusts for $5.2 million of acquisition expenses, was $37.9 million, or $0.24 per diluted share. The FFO indicates that the Company should be able to comfortably cover the dividend payout.

Physicians Realty Trust’s cash and cash equivalents were $11.51 million at June 30, 2017, compared to $15.49 million at December 31, 2016. The Company’s strong financial position indicates its ability to absorb any fluctuations in earnings and cash flow and to sustain its dividend distribution for a long period.

Recent Development for Physicians Realty

On September 11, 2017, Physicians Realty Trust announced that it has completed acquisitions of eight medical office facilities since June 30, 2017. The facilities represent approximately 417,753 square feet with a total purchase price of $129.7 million at an average first-year cash yield of 6.1%, and bring year-to-date investment activity to $966.2 million. The Company is also announcing fully executed purchase and sale agreements to acquire an additional two medical office facilities totaling approximately 390,033 square feet for $166.0 million at an average first-year cash yield of 4.8%.

About Physicians Realty Trust

Physicians Realty Trust is a self-managed healthcare real estate Company organized to acquire, selectively develop, own, and manage healthcare properties that are leased to physicians, hospitals, and healthcare delivery systems. The Company invests in real estate that is integral to providing high-quality healthcare. The Company conducts its business through an UPREIT structure in which its properties are owned by Physicians Realty L.P., a Delaware limited partnership, directly or through limited partnerships, limited liability companies or other subsidiaries. The Company is the sole general partner of the operating partnership and, as of June 30, 2017, owned approximately 96.7% of the partnership interests in its operating partnership.

Stock Performance

At the close of trading session on Thursday, September 28, 2017, Physicians Realty Trust’s stock price rose 1.72% to end the day at $17.79. A total volume of 1.42 million shares were exchanged during the session. The Company’s shares are trading at a PE ratio of 76.03 and have a dividend yield of 5.17%. At Thursday’s closing price, the stock’s net capitalization stands at $3.22 billion.

Pro-Trader Daily:

Pro-Trader Daily (Pro-TD) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and Canadian stocks. PRO-TD has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles, and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

PRO-TD has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the “Author”) and is fact checked and reviewed by a third party research service company (the “Reviewer”) represented by a credentialed financial analyst [for further information on analyst credentials, please email contact@protraderdaily.com. Rohit Tuli, a CFA® charter-holder (the “Sponsor”), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by PRO-TD. PRO-TD is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

PRO-TD, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. PRO-TD, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, PRO-TD, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither PRO-TD nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://protraderdaily.com/disclaimer/.

CONTACT

For any questions, inquiries, or comments reach out to us directly. If you’re a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:

Email: contact@protraderdaily.com

Phone number: (917) 341.4653

Office Address: Mainzer Landstrasse 50 Frankfurt am Main, Germany 60325

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: Pro-Trader Daily

ReleaseID: 476648

LONDON, UK / ACCESSWIRE / September 29, 2017 /Pro-Trader Daily takes a look at the latest corporate events and news making the headlines for Nokia Corp. (NYSE: NOK), following which we have published a free report that can be viewed by signing up at http://protraderdaily.com/optin/?symbol=NOK. The Company announced on September 27, 2017, that it will help Idea Cellular meet the ever-increasing bandwidth demand by deploying the Nokia 1830 Photonic Services Switch (PSS) based Wavelength Division Multiplexing (WDM) solution. The optical transport network solution will be implemented across fiber-constrained geographies on the Idea Cellular network. The technology, once implemented, would enable Idea Cellular to deliver high-bandwidth services to its customers. For immediate access to our complimentary reports, including today’s coverage, register for free now at:

http://protraderdaily.com/register/

At Pro-TD, we make it our mission to bring you news that matter about the stock you follow. Today, our research desk covers a blog story on NOK. Go directly to your stock of interest and access today’s free coverage at:

http://protraderdaily.com/optin/?symbol=NOK

The Announcement

The Company stated that through a blend of new operator offerings, data plans, and massive adoption of smartphones, India has observed unprecedented data usage growth since the start of 2017. Nokia announced that it would deploy the optical transport network while working with Idea Cellular, which would eventually help address the high-bandwidth data demands of its customers. Idea Cellular views this agreement as a step to satisfy the growing need of high bandwidth. Owing to a long-standing relationship with Nokia, the Companies will deploy optical network, as done in Radio, Core, and IP Domains.

Nokia 1830 Photonic Services Switch

The switch from Nokia allows service providers to extend their outreach by offering a cost-effective alternative to expensive fiber. The Company’s solution will be deployed in fast-growing areas to enable Idea Cellular to deliver high-bandwidth services to its subscribers without worrying about the enhanced load on the network. The new transport network would also support increased demand in the future, wherein Nokia WDM would help in creating a new access layer which would be easily scalable and ensure efficient power consumption optimization. Also, the Company announced that the Nokia Professional Services will be leveraged for installing and commissioning, project management, training, and support for a lag-free execution of the project.

Company Growth Prospects

Recently, on September 25, 2017, the Company announced that it is expanding its ViTrust critical communications portfolio with new services to help first responders take advantage of reliable and secure high-performance application on their public safety devices. The services include trouble-free continuity of operations for public safety agencies across a multi-vendor, multi-technology mission-critical communications environment.

Nokia also announced on September 25, 2017, that it has delivered DCI solution for Internet Thailand Public Co. Ltd., marking one of the first long-haul DCI solutions in the country. Nokia will leverage its Dense Wavelength Division Multiplexing (DWDM) technology to connect INET’s two data centers in the capital city of Bangkok to a site in Saraburi.

Nokia stated that its device software customization service would help accelerate agency adoption of Android-based devices for first responders. The Company’s experts design and develop secure custom device firmware with tailor-made user experience adaptations and enhancements for public safety operations. According to Nokia, its expertise in end-to-end LTE Solutions across devices, operating systems, applications, and network nodes assures extreme performance and reliability for real-time video and other mission-critical broadband applications, integrated with custom-built firmware. The build is also hardened for security and incorporates features including data encryption and controlled access to external sources like application stores.

Last Close Stock Review

At the closing bell, on Thursday, September 28, 2017, Nokia’s stock marginally climbed 0.34%, ending the trading session at $5.90. A total volume of 7.99 million shares have exchanged hands. The Company’s stock price advanced 10.69% in the past six months and 2.79% in the previous twelve months. Moreover, the stock rallied 22.66% since the start of the year. The stock has a dividend yield of 3.05% and currently has a market cap of $34.94 billion.

Pro-Trader Daily:

Pro-Trader Daily (Pro-TD) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and Canadian stocks. PRO-TD has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles, and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

PRO-TD has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the “Author”) and is fact checked and reviewed by a third party research service company (the “Reviewer”) represented by a credentialed financial analyst [for further information on analyst credentials, please email contact@protraderdaily.com. Rohit Tuli, a CFA® charter-holder (the “Sponsor”), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by PRO-TD. PRO-TD is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

PRO-TD, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. PRO-TD, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, PRO-TD, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither PRO-TD nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://protraderdaily.com/disclaimer/.

CONTACT

For any questions, inquiries, or comments reach out to us directly. If you’re a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:

Email: contact@protraderdaily.com

Phone number: (917) 341.4653

Office Address: Mainzer Landstrasse 50 Frankfurt am Main, Germany 60325

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: Pro-Trader Daily

ReleaseID: 476647

LONDON, UK / ACCESSWIRE / September 29, 2017 / Pro-Trader Daily has just published a free post-earnings coverage on Pluristem Therapeutics Inc. (NASDAQ: PSTI) (“Pluristem”), which can be viewed by registering at http://protraderdaily.com/optin/?symbol=PSTI, following the Company’s disclosure of its financial results on September 11, 2017, for the fourth quarter of the fiscal year 2017. The Company received an $8.7 million non-dilutive grant from the European Union’s Horizon 2020 Program. Our daily stock reports are accessible for free, and with those to look forward today you also will be signing up for a complimentary member’s account at:

http://protraderdaily.com/register/

At Pro-TD, we make it our mission to bring you news that matter about the stock you follow. Today, our research desk covers a blog story on PSTI. With the links below you can directly download the report of your stock of interest free of charge at:

http://protraderdaily.com/optin/?symbol=PSTI

Earnings Reviewed

Pluristem did not recognize revenues in FY17 compared to revenues of $2.847 million and $379,000 for the fiscal years ended June 30, 2016, and June 30, 2015, respectively. All revenues in the fiscal year 2016 and fiscal year 2015 were derived from a prior license agreement with United Therapeutics Corp.

During FY17, Pluristem’s G&A expenses increased 6.7% to $6.93 million from $6.49 million in FY16. During the year, the Company’s net R&D expenses increased 7.7% to $21.09 million from $19.58 million in FY16.

During FY17, Pluristem’s operating loss was $28.02 million compared to an operating loss of $23.32 million in FY16.

During FY17, Pluristem’s net loss was $27.81 million compared to a net loss of $23.25 million in FY16. During FY17, Pluristem’s diluted earnings per share (EPS) was negative $0.32 compared to a negative diluted EPS of $0.29 in FY16.

During Q4 FY17, Pluristem received approval for a $1.5 million grant from the Israel Innovation Authority to support the PLX-PAD program and was also awarded a Smart Money grant from Israel’s Ministry of Economy and Industry to advance its product candidates towards marketing in the China-Hong Kong markets. The Company’s PLX-R18 Program also received $900,000 in funding from the Israel-US Binational Industrial Research and Development Foundation (BIRD) for a collaborative study with the New York Blood Center on umbilical cord blood transplantation.

In August 2017, the Company announced that the US DOD will examine whether PLX-R18 administered prior to, or within the first 24 hours of exposure to radiation will mitigate ARS.

On September 05, 2017, Pluristem received an $8.7 million non-dilutive grant from the European Union’s Horizon 2020 program for the Company’s planned Phase-III study to support recovery following surgery for hip fracture.

Balance Sheet

As of June 30, 2017, Pluristem’s cash and cash equivalents decreased 24.2% to $4.71 million from $6.22 million in FY16.

During FY17, the Company’s total assets decreased 18.3% to $37.53 million from $45.94 million in FY16.

During FY17, the Company’s trade payables decreased 27.3% to $1.97 million from $2.71 million in FY16.

During FY17, the Company’s accrued expenses increased 7.2% to $1.47 million from $1.37 million in FY16.

During FY17, the Company’s cash used for operating activities was $21.61 million compared to $18.52 million in FY16.

Outlook

For FY18, Pluristem expects to complete a partnership deal in Asia; continued development of the ARS project including 3rd party funding of pivotal studies from the US government; expected data readouts from several clinical trials; launch of its phase-III study for hip fracture; preparations for Biological License Application (BLA) submission in ARS; and meeting enrollment goals for its CLI study.

Stock Performance

On Thursday, September 28, 2017, the stock closed the trading session at $1.51, dropping 2.58% from its previous closing price of $1.55. A total volume of 255.47 thousand shares have exchanged hands. Pluristem Therapeutics’ stock price surged 26.89% in the last one month, 17.05% in the past three months, and 24.79% in the previous six months. Furthermore, since the start of the year, shares of the Company have gained 5.59%. The stock currently has a market cap of $149.43 million.

Pro-Trader Daily:

Pro-Trader Daily (Pro-TD) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and Canadian stocks. PRO-TD has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles, and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

PRO-TD has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the “Author”) and is fact checked and reviewed by a third party research service company (the “Reviewer”) represented by a credentialed financial analyst [for further information on analyst credentials, please email contact@protraderdaily.com. Rohit Tuli, a CFA® charter-holder (the “Sponsor”), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by PRO-TD. PRO-TD is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

PRO-TD, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. PRO-TD, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, PRO-TD, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither PRO-TD nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://protraderdaily.com/disclaimer/.

CONTACT

For any questions, inquiries, or comments reach out to us directly. If you’re a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:

Email: contact@protraderdaily.com

Phone number: (917) 341.4653

Office Address: Mainzer Landstrasse 50 Frankfurt am Main, Germany 60325

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: Pro-Trader Daily

ReleaseID: 476649

LONDON, UK / ACCESSWIRE / September 29, 2017 / Pro-Trader Daily takes a closer look at Quest Diagnostics Inc. (NYSE: DGX) as the Company’s stock will begin trading ex-dividend on October 02, 2017. To capture the dividend payout, investors must purchase the stock a day prior (excluding weekend) to the ex-dividend date that is by latest at the end of the trading session on September 29, 2017. Are you looking for research on dividend stocks, if so register with us now for your free membership at:

http://protraderdaily.com/register/

Today, PRO-TD covers ex-dividend news on DGX. Get our free coverage by signing up at:

http://protraderdaily.com/optin/?symbol=DGX

Dividend Declared

On August 18, 2017, Quest Diagnostics announced that its Board of Directors declared a quarterly cash dividend of $0.45 per share, payable on October 18, 2017, to shareholders of record of Quest Diagnostics common stock on October 03, 2017.

Quest Diagnostics’ indicated dividend represents a yield of 1.91%, which is substantially above the average dividend yield of 0.65% for the Healthcare sector. The Company has raised its dividend for five consecutive years.

Dividend Insights

Quest Diagnostics has a dividend payout ratio of 31.6%, which indicates that it distributes approximately $0.32 for every $1.00 earned. The dividend payout ratio reflects how much amount a company is returning to shareholders versus how much money it is keeping on hand to reinvest in growth, to pay off debt, and/or to add to its cash reserves.

According to analysts’ estimates, Quest Diagnostics is forecasted to report earnings of $5.96 per share in the coming year, which is more than three times the Company’s annualized dividend of $1.80.

At June 30, 2017, Quest Diagnostics’ cash and cash equivalents totaled $314 million versus cash worth $59 million at December 31, 2016. The Company’s net cash provided by operating activities totaled $294 million for the three months ended June 30, 2017, compared to operating cash flows of $311 million for the three months ended June 30, 2016. The Company’s strong financial position indicates its ability to absorb any fluctuations in earnings and cash flow and to sustain its dividend distribution for a long period.

Recent Development for Quest Diagnostics

On September 13, 2017, Quest Diagnostics announced that it was named for the thirteenth consecutive year in the North America Dow Jones Sustainability Index (DJSI) and for a fourteenth year in the World DJSI.

Quest Diagnostics was one of only nine Health Care Equipment and Services companies listed on the Dow Jones Sustainability North America Index and one of only twelve companies listed on the Dow Jones Sustainability World Index in the same category. Over last year, the Company improved its percentile ranking in the areas of Risk & Crisis Management and Human Capital Development.

Launched in 1999, the DJSI World represents the gold standard for corporate sustainability and is the first global index to track the leading sustainability-driven companies based on RobecoSAM’s analysis of financially material Environmental, Social, and Governance (ESG) factors, and S&P DJI’s robust index methodology.

About Quest Diagnostics Inc.

Quest Diagnostics provides diagnostic testing information and services in the United States and internationally. The Company annually serves one in three adult Americans and half the physicians and hospitals in the United States. Quest Diagnostics was founded in 1967 and is headquartered in Madison, New Jersey.

Stock Performance

At the closing bell, on Thursday, September 28, 2017, Quest Diagnostics’ stock slipped 1.21%, ending the trading session at $91.96. A total volume of 2.30 million shares have exchanged hands, which was higher than the 3-month average volume of 941.81 thousand shares. The Company’s stock price advanced 8.26% in the previous twelve months. Moreover, the stock gained 0.07% since the start of the year. The stock is trading at a PE ratio of 18.38 and has a dividend yield of 1.96%. The stock currently has a market cap of $12.60 billion.

Pro-Trader Daily:

Pro-Trader Daily (Pro-TD) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and Canadian stocks. PRO-TD has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles, and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

PRO-TD has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the “Author”) and is fact checked and reviewed by a third party research service company (the “Reviewer”) represented by a credentialed financial analyst [for further information on analyst credentials, please email contact@protraderdaily.com. Rohit Tuli, a CFA® charter-holder (the “Sponsor”), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by PRO-TD. PRO-TD is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

PRO-TD, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. PRO-TD, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, PRO-TD, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither PRO-TD nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://protraderdaily.com/disclaimer/.

CONTACT

For any questions, inquiries, or comments reach out to us directly. If you’re a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:

Email: contact@protraderdaily.com

Phone number: (917) 341.4653

Office Address: Mainzer Landstrasse 50 Frankfurt am Main, Germany 60325

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: Pro-Trader Daily

ReleaseID: 476650

LONDON, UK / ACCESSWIRE / September 29, 2017 / Pro-Trader Daily has just published a free post-earnings coverage on SecureWorks Corp. (NASDAQ: SCWX), which can be viewed by registering at http://protraderdaily.com/optin/?symbol=SCWX, following the Company’s reporting of its financial results for the second quarter fiscal 2018 (Q2 FY18) on September 06, 2017. The Atlanta, Georgia-based Company’s non-GAAP revenues and grew 11.9% y-o-y, outperforming market consensus estimates. Our daily stock reports are accessible for free, and with those to look forward today you also will be signing up for a complimentary member’s account at:

http://protraderdaily.com/register/

At Pro-TD, we make it our mission to bring you news that matter about the stock you follow. Today, our research desk covers a blog story on SCWX. With the links below you can directly download the report of your stock of interest free of charge at:

http://protraderdaily.com/optin/?symbol=SCWX

Earnings Reviewed

For the three months ended on August 04, 2017, SecureWorks reported GAAP net revenues of $116.12 million, which came in above the $103.65 million recorded at the end of Q2 FY17. The Company non-GAAP total revenues increased to $116.27 million in Q2 FY18 from $103.87 million in Q2 FY17. Furthermore, non-GAAP total revenues numbers beat market forecasts of $113.7 million.

The information security services provider posted GAAP net loss of $12.12 million, or $0.15 loss per diluted share, in Q2 FY18 compared to GAAP net loss $12.05 million, or $0.15 loss per diluted share, in Q2 FY17. Meanwhile, the Company’s non-GAAP net loss stood at $5.36 million, or $0.07 loss per diluted share, in Q2 FY18 compared to non-GAAP net loss of $5.58 million, or $0.07 loss per diluted share, in Q2 FY17. Wall Street had expected the Company to report non-GAAP net loss of $0.09 per diluted share.

Operational Metrics

In the reported quarter, the Company’s non-GAAP gross margin for Q2 FY18 stood at $63.58 million, or 54.7% of revenues, compared to $54.67 million, or 52.6% of revenues, in the previous year’s same quarter. The Company’s non-GAAP research and development (R&D) expenses for Q2 FY17 came in at $18.93 million, or 16.3% of revenues, compared to $16.69 million, or 16.1% of revenues, in Q2 FY17. Non-GAAP sales and marketing (S&M) expenses increased during Q2 FY18 to $37.21 million, or 32.0% of revenues from $31.46 million, or 30.3% of revenues, in the last year’s comparable quarter. Furthermore, non-GAAP general and administrative (G&A) expenses stood at $15.22 million, or 13.1% of revenues, for Q2 FY18 versus $16.10 million, or 15.5% of revenues, in Q2 FY17.

Meanwhile, the Company’s non-GAAP operating loss narrowed to $7.78 million, or 6.7% of revenues, during the reported quarter from non-GAAP operating loss $9.58 million, or 9.2% of revenues, in Q2 FY17. Furthermore, the Company reported negative adjusted earnings before interest, tax, depreciation, and amortization (EBITDA) of $4.57 million during Q2 FY18 compared to negative adjusted EBITDA of $7.03 million in Q2 FY17.

Cash Flow & Balance Sheet

During the first six months ended on August 04, 2017, SecureWorks used $8.42 million of cash in its operating activities versus net cash used in operating activities $21.58 million in the prior year’s comparable quarter. The Company had $97.78 million in cash and cash equivalents as on August 04, 2017, compared to $116.60 million as on February 03, 2017.

Outlook

In its outlook for the year ending February 02, 2018, SecureWorks expects non-GAAP revenues in the range of $463 million to $466 million. Non-GAAP net loss per share for full-year FY18 is projected to be in the range of $0.29 to $0.32.

For Q3 FY18, the Company’s GAAP and non-GAAP revenues is anticipated to be in the range of $115 million to $116 million. Moreover, non-GAAP net loss per share for Q3 FY18 is forecasted to be in the range of $0.09 to $0.10.

Stock Performance

At the closing bell, on Thursday, September 28, 2017, SecureWorks’ stock slipped 1.26%, ending the trading session at $12.54. A total volume of 74.36 thousand shares have exchanged hands. The Company’s stock price soared 21.16% in the previous one month, 35.28% in the last three months and 29.55% in the past six months. Moreover, the stock surged 18.41% since the start of the year. The stock currently has a market cap of $1.00 billion.

Pro-Trader Daily:

Pro-Trader Daily (Pro-TD) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and Canadian stocks. PRO-TD has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles, and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

PRO-TD has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the “Author”) and is fact checked and reviewed by a third party research service company (the “Reviewer”) represented by a credentialed financial analyst [for further information on analyst credentials, please email contact@protraderdaily.com. Rohit Tuli, a CFA® charter-holder (the “Sponsor”), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by PRO-TD. PRO-TD is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

PRO-TD, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. PRO-TD, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, PRO-TD, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither PRO-TD nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://protraderdaily.com/disclaimer/.

CONTACT

For any questions, inquiries, or comments reach out to us directly. If you’re a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:

Email: contact@protraderdaily.com

Phone number: (917) 341.4653

Office Address: Mainzer Landstrasse 50 Frankfurt am Main, Germany 60325

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: Pro-Trader Daily

ReleaseID: 476654

LONDON, UK / ACCESSWIRE / September 29, 2017 / Pro-Trader Daily looks at the latest corporate events and news making the headlines for Remark Holdings Inc. (NASDAQ: MARK), following which we have published a free report that can be viewed by signing up at http://protraderdaily.com/optin/?symbol=MARK. The Company announced on September 27, 2017, that one of the largest state-owned enterprises in China has awarded a seven-figure contract to the Company for providing a facial and object recognition technology to a Shanghai municipal health agency. The technology is intended to ensure that restaurants comply with local food safety laws. For immediate access to our complimentary reports, including today’s coverage, register for free now at:

http://protraderdaily.com/register/

At Pro-TD, we make it our mission to bring you news that matter about the stock you follow. Today, our research desk covers a blog story on MARK. Go directly to your stock of interest and access today’s free coverage at:

http://protraderdaily.com/optin/?symbol=MARK

How Technology Works?

The technology, utilizing artificial intelligence (AI), will be initially installed in 200 restaurants and later will be expanded to around 2,000 facilities.
It instantly analyzes the images obtained from an AI device designed by KanKan and attached to cameras installed in a restaurant kitchen.
In the next step, the software detects any violation of the specified food safety laws and extracts screen images, with violation details, that can be reviewed by the health agency.

The Same Safety-Enforcement System can be used in Many Other Situations

Kai-Shing Tao, Chairman and CEO of Remark Holdings, stated that this contract shows that the Company can monetize its AI technology, including facial and object recognition and it sets the foundation to potentially triple its business with the city of Shanghai in 2018 and expand to most of the eight million restaurants located in cities throughout China. He further added that this same safety-enforcement system, which is largely automated, scalable and which helps eliminate human error, can be used in many other situations, such as at construction sites to ensure the use of hard hats and goggles for workplace safety.

KanKan AI Platform

The KanKan AI Platform is designed as a one-stop shop providing small to large enterprises and developers the ability to customize and train their own AI models for their businesses.
Remark Holdings utilizes KanKan’s extensive data sets to train its KanKan AI Platform with millions of supervised and unsupervised samples.
It helps the Company in developing models that extract facial features and recognize objects, such as branded logos, animals or license plates, with a high degree of precision.
Accuracy rate of more than 96% has been observed in KanKan’s facial-recognition and object-recognition technology.

About Remark Holdings Inc.

Founded in 2006, Remark Holdings Inc. focuses on the development and deployment of artificial-intelligence-based solutions for businesses and software developers in many industries. The Company operates KanKan, a social media application and data intelligence platform, which aggregates content and consumer-shopping data across social media platforms. Headquartered in Las Vegas, Nevada, Remark Holdings has additional offices in Los Angeles, California and in Beijing, Shanghai, Chengdu and Hangzhou, China.

Last Close Stock Review

On Thursday, September 28, 2017, the stock closed the trading session at $3.78, slightly down 0.79% from its previous closing price of $3.81. A total volume of 1.31 million shares have exchanged hands, which was higher than the 3-month average volume of 163.38 thousand shares. Remark Holdings’ stock price skyrocketed 68.00% in the last one month, 35.48% in the past three months, and 26.00% in the previous six months. The stock currently has a market cap of $87.77 million.

Pro-Trader Daily:

Pro-Trader Daily (Pro-TD) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and Canadian stocks. PRO-TD has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles, and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

PRO-TD has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the “Author”) and is fact checked and reviewed by a third party research service company (the “Reviewer”) represented by a credentialed financial analyst [for further information on analyst credentials, please email contact@protraderdaily.com. Rohit Tuli, a CFA® charter-holder (the “Sponsor”), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by PRO-TD. PRO-TD is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

PRO-TD, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. PRO-TD, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, PRO-TD, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither PRO-TD nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://protraderdaily.com/disclaimer/.

CONTACT

For any questions, inquiries, or comments reach out to us directly. If you’re a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:

Email: contact@protraderdaily.com

Phone number: (917) 341.4653

Office Address: Mainzer Landstrasse 50 Frankfurt am Main, Germany 60325

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: Pro-Trader Daily

ReleaseID: 476651

LONDON, UK / ACCESSWIRE / September 29, 2017 / Pro-Trader Daily has just published a free post-earnings coverage on SeaChange International, Inc. (NASDAQ: SEAC) (“SeaChange”), which can be viewed by registering at http://protraderdaily.com/optin/?symbol=SEAC, following the Company’s release of its second quarter fiscal 2018 financial results on September 06, 2017. The video software Company’s net loss narrowed on a y-o-y basis. Our daily stock reports are accessible for free, and with those to look forward today you also will be signing up for a complimentary member’s account at:

http://protraderdaily.com/register/

At Pro-TD, we make it our mission to bring you news that matter about the stock you follow. Today, our research desk covers a blog story on SEAC. With the links below you can directly download the report of your stock of interest free of charge at:

http://protraderdaily.com/optin/?symbol=SEAC

Earnings Reviewed

SeaChange reported second-quarter fiscal 2018 revenue of $17.2 million compared to revenue of $18.5 million in Q2 FY17. The Company’s revenue number topped analysts’ estimates of $17.94 million.

SeaChange’s blended GAAP gross profit margin increased to 66% in Q2 FY18 compared to 44% in Q2 FY17, driven by product mix and efficiencies generated from the Company’s restructuring program. Excluding the provision for loss contract and other non-GAAP charges in the reported quarter, SeaChange’s blended non-GAAP gross profit margin was 63% compared to 46% in the prior year’s same quarter.

For Q2 FY18, SeaChange posted GAAP loss from operations of $2.1 million, or $0.06 per basic share, compared to Q2 FY17 GAAP loss from operations of $11.7 million, or $0.33 per basic share. The Company’s reported quarter results included non-GAAP charges of $1.1 million, stock-based compensation of $0.7 million, amortization of intangible assets from prior acquisitions of $0.6 million and a reduction of $0.8 million in the previously recorded provision for loss contract, while the year-ago corresponding period results included $4.1 million of non-GAAP charges.

SeaChange’s non-GAAP loss from operations for Q2 FY18 was $1.0 million, or $0.03 per basic share, compared to Q2 FY17 non-GAAP loss from operations of $7.6 million, or $0.21 per basic share. The Company’s results were better than Wall Street’s estimates for a loss of $0.06 per share.

SeaChange’s Segment Results

During Q2 FY18, Video platform software revenue totaled $3.6 million and accounted for 71% of the total product revenue compared to $1.8 million or 70% of the total product revenue in Q2 FY17. The remaining product revenues of $1.5 million included revenues for user experience and hardware.

Total service revenue was $12.2 million, or 71% of total revenue, in Q2 FY18 compared to $15.9 million, or 86% of total revenue, in Q2 FY17. The Company’s Cideo platform professional service’s revenue totaled $3 million in the reported quarter, down from $5.7 million in the prior year’s same quarter.

The Maintenance revenue totaled $8.7 million, or 51% of total revenue and 72% of total service revenue, in Q2 FY18 compared to $9.1 million, or 49% of total revenue and 57% of total service revenue, in Q2 FY17. The decline in maintenance revenue was driven by the decrease in legacy video streamer support.

For Q2 FY18, the Company’s revenue from international customers was $10.2 million, which accounted for 59% of total revenue compared to $11.8 million, or 64% of total revenue, in Q2 FY17.

Backlog

SeaChange ended Q2 FY18 with $9 million in total backlog, excluding maintenance and support. The Company booked new business of $10 million during the reported quarter, ending Q2 FY18 with a backlog of $11 million.

Cash Matters

SeaChange ended Q2 FY18 with cash, cash equivalents, restricted cash, and marketable securities of approximately $36 million, with no debt outstanding. In the reported quarter, the Company’s cash decreased by approximately $900,000, mainly associated with the operating loss for the reported quarter.

SeaChange’s deferred revenue of $14.5 million increased from $12.1 million in Q2 FY17 due to an increase in deferred revenue related to the Company’s subscription business deals as well as annual service contract billings in the reported quarter versus the year-earlier comparable quarter. SeaChange’s unbilled receivables were $4.3 million in Q2 FY18 compared to $11.6 million in Q2 FY17.

Outlook

SeaChange anticipates Q3 FY18 revenue to be in the range of $19 million to $21 million, GAAP loss from operations to be in the band of $0.04 to $0.01 per basic share, and non-GAAP income from operations to be in the range of $0.00 to $0.03 per diluted share. For FY18, the Company lowered and narrowed its expectations to revenue in the range of $75 million to $80 million, GAAP loss from operations in between $0.28 to $0.23 per basic share, and non-GAAP operating income in the band of a loss of $0.03 per basic share to income of $0.02 per diluted share.

Stock Performance

On Thursday, September 28, 2017, the stock closed the trading session at $2.77, climbing 1.09% from its previous closing price of $2.74. A total volume of 43.40 thousand shares have exchanged hands. SeaChange Intl.’s stock price rallied 6.13% in the last one month, 2.59% in the past three months, and 13.52% in the previous six months. Furthermore, since the start of the year, shares of the Company have surged 20.43%. The stock currently has a market cap of $97.92 million.

Pro-Trader Daily:

Pro-Trader Daily (Pro-TD) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and Canadian stocks. PRO-TD has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles, and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

PRO-TD has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the “Author”) and is fact checked and reviewed by a third party research service company (the “Reviewer”) represented by a credentialed financial analyst [for further information on analyst credentials, please email contact@protraderdaily.com. Rohit Tuli, a CFA® charter-holder (the “Sponsor”), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by PRO-TD. PRO-TD is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

PRO-TD, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. PRO-TD, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, PRO-TD, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither PRO-TD nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://protraderdaily.com/disclaimer/.

CONTACT

For any questions, inquiries, or comments reach out to us directly. If you’re a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:

Email: contact@protraderdaily.com

Phone number: (917) 341.4653

Office Address: Mainzer Landstrasse 50 Frankfurt am Main, Germany 60325

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: Pro-Trader Daily

ReleaseID: 476653